Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

A new method accurately measures nine specific hormones in human blood.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

High androgen levels can cause hirsutism and increase inflammation.

Higher sebum levels are linked to more severe male baldness.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

Insulin resistance and nesfatin-1 are linked to acne severity.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Cyclosporine A therapy changes sex hormone levels differently in pre-menopausal and post-menopausal women with primary biliary cirrhosis.

Sex steroids influence skin appendage function and neoplasm development, with changes in AR and ERalpha in certain gland neoplasms.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

No link found between specific genes and female pattern hair loss.

People with alopecia areata often have lower vitamin D levels than healthy people.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Calprotectin levels are higher in alopecia areata patients, indicating systemic inflammation.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Finasteride lowers cortisol and raises testosterone levels in rats.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

A new gene, JMJD1C, may affect testosterone levels in men.